These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 2699507

  • 1. Lymphomagenesis in Emu-myc transgenic mice does not require transgene rearrangement or mutation of myc exon 1.
    Webb E, Barri G, Cory S, Adams JM.
    Mol Biol Med; 1989 Dec; 6(6):475-80. PubMed ID: 2699507
    [Abstract] [Full Text] [Related]

  • 2. v-myc and v-raf act synergistically to induce B-cell tumors in pristane-primed adult BALBC mice.
    Kurie JM, Morse HC, Principato MA, Wax JS, Troppmair J, Rapp UR, Potter M, Mushinski JF.
    Oncogene; 1990 Apr; 5(4):577-82. PubMed ID: 2183159
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The functional basis of c-myc and bcl-2 complementation during multistep lymphomagenesis in vivo.
    Marin MC, Hsu B, Stephens LC, Brisbay S, McDonnell TJ.
    Exp Cell Res; 1995 Apr; 217(2):240-7. PubMed ID: 7698223
    [Abstract] [Full Text] [Related]

  • 5. The human Nramp2 gene: characterization of the gene structure, alternative splicing, promoter region and polymorphisms.
    Lee PL, Gelbart T, West C, Halloran C, Beutler E.
    Blood Cells Mol Dis; 1998 Jun; 24(2):199-215. PubMed ID: 9642100
    [Abstract] [Full Text] [Related]

  • 6. Carcinogen-induced lymphomagenesis in pim-1 transgenic mice: dose dependence and involvement of myc and ras.
    Breuer M, Wientjens E, Verbeek S, Slebos R, Berns A.
    Cancer Res; 1991 Feb 01; 51(3):958-63. PubMed ID: 1988138
    [Abstract] [Full Text] [Related]

  • 7. Id2 is dispensable for myc-induced lymphomagenesis.
    Nilsson JA, Nilsson LM, Keller U, Yokota Y, Boyd K, Cleveland JL.
    Cancer Res; 2004 Oct 15; 64(20):7296-301. PubMed ID: 15492249
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. AID and RAG1 do not contribute to lymphomagenesis in Emu c-myc transgenic mice.
    Nepal RM, Zaheen A, Basit W, Li L, Berger SA, Martin A.
    Oncogene; 2008 Aug 07; 27(34):4752-6. PubMed ID: 18408759
    [Abstract] [Full Text] [Related]

  • 10. c-myc gene abnormalities in mucosa-associated lymphoid tissue (MALT) lymphomas.
    Peng H, Diss T, Isaacson PG, Pan L.
    J Pathol; 1997 Apr 07; 181(4):381-6. PubMed ID: 9196434
    [Abstract] [Full Text] [Related]

  • 11. Clustered mutations in the second exon of the MYC gene in sporadic Burkitt's lymphoma.
    Yano T, Sander CA, Clark HM, Dolezal MV, Jaffe ES, Raffeld M.
    Oncogene; 1993 Oct 07; 8(10):2741-8. PubMed ID: 8397370
    [Abstract] [Full Text] [Related]

  • 12. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.
    Yu D, Thomas-Tikhonenko A.
    Oncogene; 2002 Mar 14; 21(12):1922-7. PubMed ID: 11896625
    [Abstract] [Full Text] [Related]

  • 13. Integration of a c-myc transgene results in disruption of the mouse Gtf2ird1 gene, the homologue of the human GTF2IRD1 gene hemizygously deleted in Williams-Beuren syndrome.
    Durkin ME, Keck-Waggoner CL, Popescu NC, Thorgeirsson SS.
    Genomics; 2001 Apr 01; 73(1):20-7. PubMed ID: 11352562
    [Abstract] [Full Text] [Related]

  • 14. Acceleration of B-lymphoid tumorigenesis in E mu-myc transgenic mice by v-H-ras and v-raf but not v-abl.
    Langdon WY, Harris AW, Cory S.
    Oncogene Res; 1989 Apr 01; 4(4):253-8. PubMed ID: 2549487
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
    Graham IR, Hill VJ, Manoharan M, Inamati GB, Dickson G.
    J Gene Med; 2004 Oct 01; 6(10):1149-58. PubMed ID: 15386737
    [Abstract] [Full Text] [Related]

  • 17. Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.
    Shinto Y, Morimoto M, Katsumata M, Uchida A, Aozasa K, Okamoto M, Kurosawa T, Ochi T, Greene MI, Tsujimoto Y.
    Oncogene; 1995 Nov 02; 11(9):1729-36. PubMed ID: 7478600
    [Abstract] [Full Text] [Related]

  • 18. Mouse and rat B-myc share amino acid sequence homology with the c-myc transcriptional activator domain and contain a B-myc specific carboxy terminal region.
    Asker CE, Magnusson KP, Piccoli SP, Andersson K, Klein G, Cole MD, Wiman KG.
    Oncogene; 1995 Nov 16; 11(10):1963-9. PubMed ID: 7478514
    [Abstract] [Full Text] [Related]

  • 19. Conservation and expression of an alternative 3' exon of Runx2 encoding a novel proline-rich C-terminal domain.
    Terry A, Kilbey A, Vaillant F, Stewart M, Jenkins A, Cameron E, Neil JC.
    Gene; 2004 Jul 07; 336(1):115-25. PubMed ID: 15225881
    [Abstract] [Full Text] [Related]

  • 20. Characterization of hprt splicing mutations induced by the ultimate carcinogenic metabolite of benzo[a]pyrene in Chinese hamster V-79 cells.
    Hennig EE, Conney AH, Wei SJ.
    Cancer Res; 1995 Apr 01; 55(7):1550-8. PubMed ID: 7882364
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.